Related Subjects:
|Osteoporosis
|Osteogenesis Imperfecta
β οΈ Osteogenesis Imperfecta (OI) is a dominantly inherited connective tissue disorder caused by defective type I collagen.
It is characterised by fragile, brittle bones and multiple systemic features.
Adults with OI usually have milder phenotypes (commonly Type I).
π About
- 𦴠Brittle bones: Recurrent fractures with minimal trauma.
- π Osteopenia/osteoporosis: Reduced bone mass predisposing to fragility.
- 𧬠Inheritance: Usually autosomal dominant (COL1A1, COL1A2 mutations).
- βοΈ Pathophysiology: Collagen type I is reduced in quantity or abnormal in structure β bone matrix weakened β systemic connective tissue fragility.
- π Prevalence: ~6β7 per 100,000 worldwide (rare disease).
𧬠Types of OI
- Type I (Mild): Most common. Childhood fractures, blue sclerae, hearing loss, normal stature.
- Type II (Perinatal lethal): Multiple in-utero fractures, underdeveloped lungs β neonatal death.
- Type III (Severe, progressive): Deforming, short stature, scoliosis, barrel chest, respiratory compromise.
- Type IV (Moderate): Intermediate severity; fractures before puberty, mildβmoderate deformity.
- Type V: Hypertrophic callus at fracture sites, interosseous membrane calcification.
- Type VI: Mineralisation defect seen on biopsy.
- Type VII: Rare, short femora/humeri, coxa vara; clustered in specific populations.
π©Ί Clinical Features
- π₯ Recurrent fractures (may occur during birth/infancy).
- ποΈ Blue sclerae (Types I & III most characteristic).
- πΊ Triangular facies, macrocephaly.
- π Progressive hearing loss (ossicular involvement).
- π¦· Dentinogenesis imperfecta (weak, brittle teeth).
- π« Barrel chest, scoliosis, respiratory compromise.
- π€Έ Joint laxity and dislocations.
- π Short stature in moderateβsevere forms.
π§Ύ Differentials
- β Non-accidental injury (NAI): Important to consider in children with multiple fractures β careful history, genetic testing may be needed.
- 𦴠Juvenile osteoporosis / secondary osteoporosis: Consider in older children/adults with fragility fractures.
π Investigations
- πΈ X-rays: Multiple fractures, bowing of long bones, osteopenia.
- 𧬠Genetic testing: COL1A1, COL1A2 mutations confirm diagnosis.
- π§ͺ Bone density (DEXA): Baseline and monitoring tool.
- π§ Hearing tests & dental assessment for systemic features.
π Management
- 𦴠Bisphosphonates: Reduce fracture rates & bone pain (esp. in children).
- π οΈ Orthopaedic support: Casting, splinting, intramedullary rodding for deformities, spinal fusion for scoliosis.
- π Physiotherapy & exercise: Improves muscle tone, mobility, independence.
- π§ββοΈ Multidisciplinary care: Orthopaedics, endocrinology, dentistry (for dentinogenesis), ENT (hearing loss), physiotherapy, psychology.
- π Lifestyle: avoid smoking, alcohol, and unnecessary steroids.
- πΆ Family planning: genetic counselling important.
π OSCE / Exam Pearls
- Always differentiate OI from child abuse in paediatrics.
- Blue sclerae + multiple fractures = classic OI (esp. Type I).
- Bisphosphonates improve quality of life but are not curative.
- Multidisciplinary approach is key to management.
- Hearing loss and dentinogenesis imperfecta are high-yield extra-skeletal features to mention in exams.
π― Key Takeaway
Osteogenesis Imperfecta is a collagen disorder with brittle bones and multisystem features.
Diagnosis is by clinical features, imaging, and genetic testing.
Management is supportive and multidisciplinary, with bisphosphonates, orthopaedic surgery, and rehabilitation central to care. π
π Reference
Osteogenesis Imperfecta Foundation β Medical Guide